載入...

MON-344 Uncommon Etiology of Hypophosphatemia and Secondary Hyperparathyroidism: Ferric Carboxymaltose Infusion

Background: Hypophosphatemia has been recognized as one of the side effect of intravenous ferric carboxymaltose infusion. This effect is thought to be secondary to fibroblast growth factor 23 (FGF 23) mediated renal phosphate wasting and associated with calcitriol deficiency and secondary hyperparat...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Endocr Soc
主要作者: Sever, Sakine
格式: Artigo
語言:Inglês
出版: Oxford University Press 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207565/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1626
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!